Literature DB >> 33837780

Exosome Transplantation From Patients With Schizophrenia Causes Schizophrenia-Relevant Behaviors in Mice: An Integrative Multi-omics Data Analysis.

Yang Du1, Wen-Long Tan2, Lei Chen2, Zi-Meng Yang2, Xue-Song Li3, Xiong Xue3, Yan-Shan Cai3, Yong Cheng1,2,4.   

Abstract

Exosomes are involved in the pathophysiology of neuropsychiatric diseases, but the role of exosomes in schizophrenia (SCZ) is unclear. Here, we demonstrate that transplantation of serum exosomes from SCZ patients into mice caused behavioral abnormalities such as deficits in prepulse inhibition and sociability, hyperactivity, and anxiogenesis. A comparative bioinformatics analysis suggested shared and distinct differentially expressed genes (DEGs) and enriched molecular pathways in the brains of SCZ exosome-recipient mice, methylazoxymethanol acetate-treated rats, and SCZ patients, which correlates evidence of altered prefrontal-hippocampal functional coherence in SCZ. A large proportion of SCZ-relevant DEGs in the exosome-recipient mice were targets of DE exosomal miRNAs in SCZ patients. Furthermore, we identified 20 hub genes for SCZ risk genes, including BDNF and NRG1, which were DE miRNA targets in SCZ. Collectively, our study suggests that SCZ exosome transplantation caused SCZ-relevant behaviors in mice, and epigenetic regulation may contribute to the phenotypes in the SCZ exosome-recipient mice. Our results may provide a potential animal model and novel therapeutic targets for SCZ.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  behavior; bioinformatics; exosome; miRNA; schizophrenia

Mesh:

Substances:

Year:  2021        PMID: 33837780      PMCID: PMC8379541          DOI: 10.1093/schbul/sbab039

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  8 in total

1.  MiR-574-5P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia.

Authors:  Omran Davarinejad; Sajad Najafi; Hossein Zhaleh; Farzaneh Golmohammadi; Farnaz Radmehr; Mostafa Alikhani; Reza Heidari Moghadam; Yazdan Rahmati
Journal:  J Mol Neurosci       Date:  2021-11-22       Impact factor: 3.444

Review 2.  Exosomes in schizophrenia: Pathophysiological mechanisms, biomarkers, and therapeutic targets.

Authors:  Yu Wang; Nousayhah Amdanee; Xiangrong Zhang
Journal:  Eur Psychiatry       Date:  2022-09-09       Impact factor: 7.156

Review 3.  Circular RNA: A novel and potential regulator in pathophysiology of schizophrenia.

Authors:  Mandakini Singh; Sushree Lipsa Lopamudra Dwibedy; Smruti Rekha Biswal; Srinivasan Muthuswamy; Ajay Kumar; Santosh Kumar
Journal:  Metab Brain Dis       Date:  2022-04-18       Impact factor: 3.655

4.  Paeoniflorin Rescued MK-801-Induced Schizophrenia-Like Behaviors in Mice via Oxidative Stress Pathway.

Authors:  Jia-Quan Liang; Xi Chen; Yong Cheng
Journal:  Front Nutr       Date:  2022-04-27

5.  Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia.

Authors:  Xiao-Ling Li; Yun Yu; Yang Hu; Huan-Tong Wu; Xue-Song Li; Guang-Yang Chen; Yong Cheng
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

Review 6.  [The sensorimotor domain in the research domain criteria system: progress and perspectives].

Authors:  Dusan Hirjak; Stefan Fritze; Georg Northoff; Katharina M Kubera; Robert Christian Wolf
Journal:  Nervenarzt       Date:  2021-06-11       Impact factor: 1.214

7.  CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations.

Authors:  Yong-Hang Li; Wei Huang; Man-Yu Xiao; Shi-Qing Huang; Hui Chen; Zai-Fang Li; Xue-Song Li; Yong Cheng
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-02       Impact factor: 2.570

8.  Intranasal Administration of Brain-Derived Neurotrophic Factor Rescues Depressive-Like Phenotypes in Chronic Unpredictable Mild Stress Mice.

Authors:  Xiao-Ling Li; Hua Liu; Shu-Han Liu; Yong Cheng; Guo-Jun Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-29       Impact factor: 2.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.